STOCK TITAN

Eli Lilly and Company (LLY) EPS by Year

LLY

Eli Lilly and Company earned $22.95 per diluted share in fiscal year 2025. This represents an increase of 96.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $29.80 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Eli Lilly and Company has filed alongside them.

FY2025 annual
EPS (Diluted) $22.95
YoY +96.0%
5Y CAGR +27.6%
10Y CAGR +26.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LLY EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)$29.80$22.95+96.0%$11.71+101.9%$5.80-15.9%$6.90+12.7%$6.12-9.9%$6.79-23.6%$8.89+184.0%$3.13+1747.4%-$0.19-107.4%$2.58+14.2%$2.26+1.3%$2.23-48.4%$4.32+18.0%$3.66-6.2%$3.90

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

LLY EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)$7.94+26.2%$8.26+169.9%$7.39+51.4%$6.21+480.4%$6.29+91.8%$3.06+23.4%$4.88+101.7%$1.07+1883.3%$3.28+68.2%$2.48+66.4%$2.42+13.1%-$0.06-103.7%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Eli Lilly and Company financials

Frequently Asked Questions

What was Eli Lilly and Company's diluted earnings per share in fiscal year 2025?

Eli Lilly and Company earned $22.95 per diluted share in fiscal year 2025.

How fast is Eli Lilly and Company's diluted earnings per share growing?

Eli Lilly and Company (LLY) diluted earnings per share rose by 96.0% year over year, from $11.71 to $22.95 in fiscal year 2025.

What is Eli Lilly and Company's diluted earnings per share over the last twelve months?

Eli Lilly and Company (LLY) reported $29.80 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Eli Lilly and Company (LLY) diluted earnings per share went from $3.90 in fiscal year 2011 to $22.95 in fiscal year 2025.

Eli Lilly and Company (LLY) reported $7.94 in diluted earnings per share in Q2 2026. This represents an increase of 26.2% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Eli Lilly and Company (LLY) reported on that line in every period on record.